This document discusses quality management in medical laboratories. It outlines the development of ISO 15189, an international standard for quality management in medical labs. ISO 15189 provides requirements for lab management, personnel, equipment, quality control, audits and continuous improvement. It emphasizes a holistic approach and aims to ensure labs are competent and provide quality patient care. The standard is gaining widespread international use and all medical lab professionals will need to understand and apply its requirements.
This document provides information on quality management for laboratories seeking NABL accreditation according to ISO 15189:2022. It defines quality as meeting customer needs and requirements. NABL oversees the accreditation process based on ISO 15189 standards. The document outlines the quality hierarchy, classification of laboratories, sequence of NABL formats, structural and process requirements, quality procedures, exhibits, standard operating procedures, sample formats, and a quality manual template addressing all ISO 15189 requirements.
ISO 15189 is an international standard that specifies the general requirements for the competence of medical laboratories. It is based on ISO 17025 for testing and calibration laboratories and ISO 9001 for quality management systems. ISO 15189 has both management and technical requirements that medical laboratories must meet in order to be accredited. The standard is designed to ensure that laboratories consistently deliver accurate, reliable and timely medical testing services.
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...akrumenaker
The document outlines best quality practices for biomedical research in drug development. It discusses establishing quality standards for non-regulated research to ensure validity and integrity of data. The technical report specifies general quality requirements covering areas like management systems, documentation, personnel training, facilities, equipment calibration and test methods. The goal is to minimize waste and costs by generating reliable data to support drug development decisions.
ISO 17025 Accreditation Detail Review Abdul Rahman
In this presentation, you would get knowledge about ISO17025. It's an updated version, terms and definitions. Which documents are required for certification.
Good Laboratory Practices Pharmaceutical Quality AssuranceShrikantKavitake1
This document provides information about Good Laboratory Practices (GLP). It discusses that GLP was created by the FDA in 1978 after cases of fraud were discovered in toxicology labs. GLP provides a framework to ensure uniformity, consistency, reliability and quality of non-clinical safety studies. It outlines principles for organization, personnel, facilities, test systems, standard operating procedures, and archiving to ensure integrity of study data and compliance. The objectives of GLP are to assure regulatory authorities that submitted data accurately reflects study results and can be relied upon for risk assessments.
Total Quality Management for Medical Labs - Ravi KumudeshRavi Kumudesh
Duties of Qualty Manager
Ensuring establishment of QMS
Implementation and Maintain QMS
Maintain Quality policy
Assist to documentation of Quality Objective
Assist to establishment of Quality Objective
Crate awareness of users in the lab
Assist preparation, administration, dissemination and regular review of quality Manual
Assist to maintaining document Control System,
Maintain Technical Records
Assist to control clinical material
Participate to Management Review
Total quality management for medical labs ravi kumudeshRavi Kumudesh
Ensuring establishment of QMS
Implementation and Maintain QMS
Maintain Quality policy
Assist to documentation of Quality Objective
Assist to establishment of Quality Objective
Crate awareness of users in the lab
Assist preparation, administration, dissemination and regular review of quality Manual
Assist to maintaining document Control System,
Maintain Technical Records
Assist to control clinical material
Participate to Management Review
This document provides information on quality management for laboratories seeking NABL accreditation according to ISO 15189:2022. It defines quality as meeting customer needs and requirements. NABL oversees the accreditation process based on ISO 15189 standards. The document outlines the quality hierarchy, classification of laboratories, sequence of NABL formats, structural and process requirements, quality procedures, exhibits, standard operating procedures, sample formats, and a quality manual template addressing all ISO 15189 requirements.
ISO 15189 is an international standard that specifies the general requirements for the competence of medical laboratories. It is based on ISO 17025 for testing and calibration laboratories and ISO 9001 for quality management systems. ISO 15189 has both management and technical requirements that medical laboratories must meet in order to be accredited. The standard is designed to ensure that laboratories consistently deliver accurate, reliable and timely medical testing services.
Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conf...akrumenaker
The document outlines best quality practices for biomedical research in drug development. It discusses establishing quality standards for non-regulated research to ensure validity and integrity of data. The technical report specifies general quality requirements covering areas like management systems, documentation, personnel training, facilities, equipment calibration and test methods. The goal is to minimize waste and costs by generating reliable data to support drug development decisions.
ISO 17025 Accreditation Detail Review Abdul Rahman
In this presentation, you would get knowledge about ISO17025. It's an updated version, terms and definitions. Which documents are required for certification.
Good Laboratory Practices Pharmaceutical Quality AssuranceShrikantKavitake1
This document provides information about Good Laboratory Practices (GLP). It discusses that GLP was created by the FDA in 1978 after cases of fraud were discovered in toxicology labs. GLP provides a framework to ensure uniformity, consistency, reliability and quality of non-clinical safety studies. It outlines principles for organization, personnel, facilities, test systems, standard operating procedures, and archiving to ensure integrity of study data and compliance. The objectives of GLP are to assure regulatory authorities that submitted data accurately reflects study results and can be relied upon for risk assessments.
Total Quality Management for Medical Labs - Ravi KumudeshRavi Kumudesh
Duties of Qualty Manager
Ensuring establishment of QMS
Implementation and Maintain QMS
Maintain Quality policy
Assist to documentation of Quality Objective
Assist to establishment of Quality Objective
Crate awareness of users in the lab
Assist preparation, administration, dissemination and regular review of quality Manual
Assist to maintaining document Control System,
Maintain Technical Records
Assist to control clinical material
Participate to Management Review
Total quality management for medical labs ravi kumudeshRavi Kumudesh
Ensuring establishment of QMS
Implementation and Maintain QMS
Maintain Quality policy
Assist to documentation of Quality Objective
Assist to establishment of Quality Objective
Crate awareness of users in the lab
Assist preparation, administration, dissemination and regular review of quality Manual
Assist to maintaining document Control System,
Maintain Technical Records
Assist to control clinical material
Participate to Management Review
The document discusses Good Laboratory Practices (GLP). It provides definitions and history of GLP. GLP refers to a quality management system for laboratories conducting non-clinical safety studies. It aims to ensure reliability and integrity of test data. Key aspects of GLP include organization, SOPs, facilities, equipment, test systems, study planning and reporting, archiving. Non-compliance can result in disqualification and rejection of study data by regulatory agencies.
Good Laboratory Practices (GLP)
History
Reason behind GLP created
Advantages and disadvantages of GLP
Objectives of GLP
Practice of GLP
b pharma 6th sem
pharmaceutical quality assurance
Clinical Trials in Russia from a central lab perspectivemichaldysko
Russia has a huge potential for clinical trials to achieve fast patient recruitment and a low drop-out rate. However, a rapidly changing regulatory environment and continuous issues with supply chain and logistics are holding up clinical study sponsors to utilize all benefits of the region.
New clinical trial regulations and restrictions are introduced almost every quarter and together with lengthy custom clearance process and poor road infrastructure, this adds to unpredicted and significant delays.
A local expert partner who has a deep knowledge of actual clinical trials regulations and legislation. Understanding the realities and requirements of the import/export process is a critical factor in the success of trials conducted in Russia.
The perfect provider would also support you in other European countries and integrate your clinical data from Russia into single harmonized database with results collected from the whole trial.
GCP, GLP and GCLP are international guidelines for clinical trials, non-clinical studies, and clinical laboratory testing. GCP ensures the rights, safety and well-being of clinical trial subjects. GLP provides standards for non-clinical laboratory studies to ensure reliable data. GCLP bridges GCP and GLP by providing quality standards for analytical laboratories involved in clinical trials to ensure reliable and traceable data. Adherence to these guidelines helps ensure ethical and scientific standards in research and regulatory acceptance of study results.
This document provides an overview of Good Laboratory Practices (GLP). It discusses that GLP is an FDA regulation that provides a framework for planning, conducting, monitoring, recording, and reporting nonclinical laboratory studies. The document outlines the history of GLP and why it was created, describes key aspects of GLP such as organization, personnel, facilities, equipment, test systems, and record keeping. It also discusses objectives of GLP and highlights an important example of a lab that was found to be fraudulent and engaged in poor practices.
This document provides an overview of Good Laboratory Practices (GLP). It discusses that GLP aims to assure regulatory authorities that safety study data submitted to them are reliable and accurate. The document traces the history and development of GLP from cases of poor laboratory practices in the 1970s. It describes the key principles of GLP including requirements for facilities, equipment, test systems, personnel responsibilities, standard operating procedures, and reporting of study results. Adherence to GLP aims to produce high quality and integrity of nonclinical safety data.
OECD principles of Good laboratory practice. this ppt include the basic and necessary information required for OECD GLP guideline . Content is taken from official site
The document discusses the basics of clinical research and clinical trials. It covers the key steps in drug discovery and development including target selection, validation, drug selection, optimization, pre-clinical and clinical testing. Clinical trials are systematic investigations in human subjects to evaluate safety and efficacy of new drugs, and are done in 4 phases. It takes approximately 10-12 years and $800 million to bring a new drug to market. Regulations, stakeholders, essential documents, and infrastructure requirements for clinical trials are also outlined.
2014 ne conference presentation by rick calabreselewiecasey
This document outlines objectives and requirements for establishing quality standards for non-regulated biomedical research in drug development. It aims to ensure reliable data generation to support investment decisions. Key points include establishing management systems, documentation procedures, technical requirements for personnel, facilities, equipment and calibration, validated test methods, and consideration of legal and ethical issues. The overall goal is to minimize waste and improve productivity in the drug development process.
The Principles of Good Laboratory Practice (GLP) are a managerial quality control system covering the organisational process and the conditions under which non-clinical health and environmental studies are planned, performed, monitored, recorded, reported and retained (or archived). The OECD Principles of GLP are followed by test facilities carrying out studies to be submitted to receiving authorities for the purposes of assessing the health and environmental safety of chemicals and chemical products which may also be of natural or biological origin and, in some circumstances, may be living organisms.
The Principles of GLP define the responsibilities of test facility management, study director, study personnel and quality assurance personnel that are operating within a GLP system, and minimum standards concerning the suitability of facilities and equipment to perform studies, the need for standard operating procedures, documentation of raw data, study reports, the archiving of records, etc.
This document discusses Good Laboratory Practice (GLP) standards and guidelines. It begins by defining GLP and explaining that GLP regulations are established by organizations like OECD and ISO to ensure quality, correctness, traceability and integrity of non-clinical study data. Key aspects of GLP include standard operating procedures (SOPs) and a Quality Assurance Unit (QAU). The document then outlines specific requirements for GLP like defining responsibilities, following SOPs, ensuring proper facilities, equipment calibration and personnel training. It describes the scope of GLP applications and differences between GLP, Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP). The roles of SOPs and QAU in maintaining standards are explained
The fundamental purposes of the Principles of Good Laboratory Practice (GLP) is to ensure the quality and integrity of test data related to non-clinical safety studies.
Good Laboratory Practice (GLP) regulations were created by the FDA in the 1970s after discovering fraudulent activities and poor lab practices that undermined the quality and integrity of data submitted to the FDA. GLP aims to ensure that studies are conducted properly according to standardized operating procedures and that accurate records are kept. This allows data from non-clinical studies to be reliably submitted to regulatory authorities. Key aspects of GLP include requirements for facilities, test systems, operating procedures, personnel qualifications, quality assurance programs, and record keeping. Following GLP helps assure reproducibility and quality of results.
This document provides information about Good Laboratory Practices (GLP). It begins with defining GLP and explaining that GLP regulations were first created in the US in 1976 and later standardized internationally by the OECD in 1981. GLP aims to ensure quality and reliability in nonclinical safety studies. The document then discusses why GLP was created, in response to issues with poor laboratory practices discovered in the 1970s. It provides advantages and disadvantages of GLP. The rest of the document outlines GLP principles regarding organization and personnel, facilities, equipment, operation of testing facilities, test articles, and protocols.
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxAtaUrRahman50751
This document discusses Good Laboratory Practice (GLP) guidelines. It was prepared by Ilyas Ahamd and Siyar Khan, who are M.Phil scholars. GLP provides a framework for planning, conducting, monitoring, recording, reporting and archiving laboratory studies to ensure the safety of users, consumers and the environment. Key aspects of GLP include qualified personnel, validated equipment and methods, standard operating procedures, accurate documentation and record keeping, quality assurance programs, and facility organization and management. GLP aims to ensure data integrity and that results submitted to regulatory agencies accurately reflect what was found in studies.
This document discusses the role of GLP compliance in generating accurate and reproducible bioequivalence data. It provides an overview of the evolution of GLP guidelines and the key fundamentals of GLP, including resources, rules and procedures, test characterization, documentation, and quality assurance. It notes that while BE studies involve human subjects and must comply with GCP, the analytical laboratory work should also adhere to GLP principles. Key regulatory guidelines on applying GLP to bioanalytical methods from the US FDA, EMEA, and ICH are summarized. Maintaining both GCP and GLP compliance through validated methods, quality systems, training and oversight can help ensure the best BE study results and regulatory acceptance.
This document provides information about quality management systems for laboratories. It discusses key aspects of a quality management system including defining quality, the importance of a QMS for ensuring reliable lab operations, and the benefits of implementing a QMS such as improved efficiency and compliance. It also outlines the 12 essential elements of an ISO-compliant lab QMS and provides details on ISO 15189, which provides standards for quality in medical laboratories.
NOIDA INSTITUTE OF ENGINEERING AND TECHNOLOGY (PHARMACY INSTITUTE) Test item characterization Presented by: Arbaz Khan M.Pharm 2nd semester Submitted to: Dr. Saumya Das Associate Professor NIET(Pharmacy Institute).
The document discusses Good Laboratory Practices (GLP). It provides definitions and history of GLP. GLP refers to a quality management system for laboratories conducting non-clinical safety studies. It aims to ensure reliability and integrity of test data. Key aspects of GLP include organization, SOPs, facilities, equipment, test systems, study planning and reporting, archiving. Non-compliance can result in disqualification and rejection of study data by regulatory agencies.
Good Laboratory Practices (GLP)
History
Reason behind GLP created
Advantages and disadvantages of GLP
Objectives of GLP
Practice of GLP
b pharma 6th sem
pharmaceutical quality assurance
Clinical Trials in Russia from a central lab perspectivemichaldysko
Russia has a huge potential for clinical trials to achieve fast patient recruitment and a low drop-out rate. However, a rapidly changing regulatory environment and continuous issues with supply chain and logistics are holding up clinical study sponsors to utilize all benefits of the region.
New clinical trial regulations and restrictions are introduced almost every quarter and together with lengthy custom clearance process and poor road infrastructure, this adds to unpredicted and significant delays.
A local expert partner who has a deep knowledge of actual clinical trials regulations and legislation. Understanding the realities and requirements of the import/export process is a critical factor in the success of trials conducted in Russia.
The perfect provider would also support you in other European countries and integrate your clinical data from Russia into single harmonized database with results collected from the whole trial.
GCP, GLP and GCLP are international guidelines for clinical trials, non-clinical studies, and clinical laboratory testing. GCP ensures the rights, safety and well-being of clinical trial subjects. GLP provides standards for non-clinical laboratory studies to ensure reliable data. GCLP bridges GCP and GLP by providing quality standards for analytical laboratories involved in clinical trials to ensure reliable and traceable data. Adherence to these guidelines helps ensure ethical and scientific standards in research and regulatory acceptance of study results.
This document provides an overview of Good Laboratory Practices (GLP). It discusses that GLP is an FDA regulation that provides a framework for planning, conducting, monitoring, recording, and reporting nonclinical laboratory studies. The document outlines the history of GLP and why it was created, describes key aspects of GLP such as organization, personnel, facilities, equipment, test systems, and record keeping. It also discusses objectives of GLP and highlights an important example of a lab that was found to be fraudulent and engaged in poor practices.
This document provides an overview of Good Laboratory Practices (GLP). It discusses that GLP aims to assure regulatory authorities that safety study data submitted to them are reliable and accurate. The document traces the history and development of GLP from cases of poor laboratory practices in the 1970s. It describes the key principles of GLP including requirements for facilities, equipment, test systems, personnel responsibilities, standard operating procedures, and reporting of study results. Adherence to GLP aims to produce high quality and integrity of nonclinical safety data.
OECD principles of Good laboratory practice. this ppt include the basic and necessary information required for OECD GLP guideline . Content is taken from official site
The document discusses the basics of clinical research and clinical trials. It covers the key steps in drug discovery and development including target selection, validation, drug selection, optimization, pre-clinical and clinical testing. Clinical trials are systematic investigations in human subjects to evaluate safety and efficacy of new drugs, and are done in 4 phases. It takes approximately 10-12 years and $800 million to bring a new drug to market. Regulations, stakeholders, essential documents, and infrastructure requirements for clinical trials are also outlined.
2014 ne conference presentation by rick calabreselewiecasey
This document outlines objectives and requirements for establishing quality standards for non-regulated biomedical research in drug development. It aims to ensure reliable data generation to support investment decisions. Key points include establishing management systems, documentation procedures, technical requirements for personnel, facilities, equipment and calibration, validated test methods, and consideration of legal and ethical issues. The overall goal is to minimize waste and improve productivity in the drug development process.
The Principles of Good Laboratory Practice (GLP) are a managerial quality control system covering the organisational process and the conditions under which non-clinical health and environmental studies are planned, performed, monitored, recorded, reported and retained (or archived). The OECD Principles of GLP are followed by test facilities carrying out studies to be submitted to receiving authorities for the purposes of assessing the health and environmental safety of chemicals and chemical products which may also be of natural or biological origin and, in some circumstances, may be living organisms.
The Principles of GLP define the responsibilities of test facility management, study director, study personnel and quality assurance personnel that are operating within a GLP system, and minimum standards concerning the suitability of facilities and equipment to perform studies, the need for standard operating procedures, documentation of raw data, study reports, the archiving of records, etc.
This document discusses Good Laboratory Practice (GLP) standards and guidelines. It begins by defining GLP and explaining that GLP regulations are established by organizations like OECD and ISO to ensure quality, correctness, traceability and integrity of non-clinical study data. Key aspects of GLP include standard operating procedures (SOPs) and a Quality Assurance Unit (QAU). The document then outlines specific requirements for GLP like defining responsibilities, following SOPs, ensuring proper facilities, equipment calibration and personnel training. It describes the scope of GLP applications and differences between GLP, Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP). The roles of SOPs and QAU in maintaining standards are explained
The fundamental purposes of the Principles of Good Laboratory Practice (GLP) is to ensure the quality and integrity of test data related to non-clinical safety studies.
Good Laboratory Practice (GLP) regulations were created by the FDA in the 1970s after discovering fraudulent activities and poor lab practices that undermined the quality and integrity of data submitted to the FDA. GLP aims to ensure that studies are conducted properly according to standardized operating procedures and that accurate records are kept. This allows data from non-clinical studies to be reliably submitted to regulatory authorities. Key aspects of GLP include requirements for facilities, test systems, operating procedures, personnel qualifications, quality assurance programs, and record keeping. Following GLP helps assure reproducibility and quality of results.
This document provides information about Good Laboratory Practices (GLP). It begins with defining GLP and explaining that GLP regulations were first created in the US in 1976 and later standardized internationally by the OECD in 1981. GLP aims to ensure quality and reliability in nonclinical safety studies. The document then discusses why GLP was created, in response to issues with poor laboratory practices discovered in the 1970s. It provides advantages and disadvantages of GLP. The rest of the document outlines GLP principles regarding organization and personnel, facilities, equipment, operation of testing facilities, test articles, and protocols.
GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxAtaUrRahman50751
This document discusses Good Laboratory Practice (GLP) guidelines. It was prepared by Ilyas Ahamd and Siyar Khan, who are M.Phil scholars. GLP provides a framework for planning, conducting, monitoring, recording, reporting and archiving laboratory studies to ensure the safety of users, consumers and the environment. Key aspects of GLP include qualified personnel, validated equipment and methods, standard operating procedures, accurate documentation and record keeping, quality assurance programs, and facility organization and management. GLP aims to ensure data integrity and that results submitted to regulatory agencies accurately reflect what was found in studies.
This document discusses the role of GLP compliance in generating accurate and reproducible bioequivalence data. It provides an overview of the evolution of GLP guidelines and the key fundamentals of GLP, including resources, rules and procedures, test characterization, documentation, and quality assurance. It notes that while BE studies involve human subjects and must comply with GCP, the analytical laboratory work should also adhere to GLP principles. Key regulatory guidelines on applying GLP to bioanalytical methods from the US FDA, EMEA, and ICH are summarized. Maintaining both GCP and GLP compliance through validated methods, quality systems, training and oversight can help ensure the best BE study results and regulatory acceptance.
This document provides information about quality management systems for laboratories. It discusses key aspects of a quality management system including defining quality, the importance of a QMS for ensuring reliable lab operations, and the benefits of implementing a QMS such as improved efficiency and compliance. It also outlines the 12 essential elements of an ISO-compliant lab QMS and provides details on ISO 15189, which provides standards for quality in medical laboratories.
NOIDA INSTITUTE OF ENGINEERING AND TECHNOLOGY (PHARMACY INSTITUTE) Test item characterization Presented by: Arbaz Khan M.Pharm 2nd semester Submitted to: Dr. Saumya Das Associate Professor NIET(Pharmacy Institute).
Similar to rt_lqm_2_quality_partnerships_and_standards_development.ppt (20)
3. 3
A quality story…
EQALM 2007
A Pathologist from London gave a presentation
on how he felt the great responsibility for being
the sole person responsible for the quality of
his medical laboratory.
4. 4
A quality story…
EQALM 2007
A Pathologist from London gave a presentation
on how he felt the great responsibility for being
the sole person responsible for the quality of his
medical laboratory.
He felt no relief when he was informed that
while he was clearly important he was far from
being the sole driver of his laboratory’s quality.
10. 10
Organizations: the quality network
ASQ US www.asq.org Website information (Free), documents ($)
CLSI US www.clsi.org Document access ($)
CMPT BC www.cmpt.ca Website information (Free),
CSA CAN www.csa.ca Website information (Free), documents ($)
DAP BC www.dap.org Website information (Free)
ISO INT www.iso.org Website information (Free), documents ($)
POLQM BC www.polqm.ca Website information (Free),
QMPLS ONT www.qmpls.org Website information (Free),
documents (Free),
SCC CAN www.scc.ca Website information (Free), documents ($)
11. 11
Organizations: the quality network
ASQ US www.asq.org Website information (Free), documents ($)
CLSI US www.clsi.org Document access ($)
CMPT BC www.cmpt.ca Website information (Free),
CSA CAN www.csa.ca Website information (Free), documents ($)
DAP BC www.dap.org Website information (Free)
ISO Int www.iso.org Website information (Free), documents ($)
POLQM BC www.polqm.ca Website information (Free),
QMPLS ONT www.qmpls.org Website information (Free),
documents (Free),
SCC CAN www.scc.ca Website information (Free), documents ($)
12. 12
Terms and Definitions
Standard:
Broad consensus document.
Authorized by an authoritative body.
Guideline:
Consensus document.
Regulation:
A regulatory (licensure) requirement.
A regulator can cite any source
document.
13. Many jurisdictions set their own standards,
guidelines, regulations, requirements
Advantages
– Fast
– Local Orientation
– Local Expertise
– Local Logic
Disadvantages
– Too introspective
– Expertise Gap
– Inconsistent with neighbours
– Lost trade opportunities
– Lost research opportunities
– Credibility Gap
– May exclude opportunities
for progress and growth.
14. Many jurisdictions set their own standards,
guidelines, regulations, requirements
Advantages
– Fast
– Local Expertise
– Local Circumstance
Disadvantages
– Too introspective
– Expertise Gap
– Inconsistent with neighbours
– Lost trade/research
opportunities
– Credibility Gap
– May become to detailed
(vertical)
LOTS OF ADVANTAGES TO SHARED DOCUMENTS
15. 15
A Brief History…
• 1995
The International Organization for
Standardization (ISO) (at the request of the
United States) invited the international medical
laboratory community to a meeting in
Philadelphia to discuss the possibility of a single
harmonizing standard for medical laboratories
– Attended by 33 countries from North America, South
America, Europe, Asia, Australasia.
16. 16
ISO Technical Committee 212
Clinical laboratory testing and in vitro diagnostic test systems
• 33 participating countries
• Argentina ( IRAM )
• Australia ( SA )
• Austria ( ON )
• Belgium ( NBN )
• Brazil ( ABNT )
• Canada ( SCC )
• Chile ( INN )
• China ( SAC )
• Czech Republic ( CNI )
• Denmark ( DS )
• Finland ( SFS )
• France ( AFNOR )
• Germany ( DIN )
• Iran, Islamic Republic of ( ISIRI )
• Ireland ( NSAI )
• Israel ( SII )
• Italy ( UNI )
• Jamaica ( BSJ )
• Japan ( JISC )
• Korea, Republic of ( KATS )
• Malaysia ( DSM )
• Mexico ( DGN )
• Netherlands ( NEN )
• New Zealand ( SNZ )
• Norway ( SN )
• Portugal ( IPQ )
• Singapore ( SPRING SG )
• Spain ( AENOR )
• Sweden ( SIS )
• Trinidad and Tobago ( TTBS )
• Turkey ( TSE )
• United Kingdom ( BSI )
17. 17
ISO Technical Committee 212
Clinical laboratory testing and in vitro diagnostic test systems
• 18 observing
countries
• Bulgaria ( BDS )
• Croatia ( HZN )
• Cuba ( NC )
• Cyprus ( CYS )
• Egypt ( EOS )
• Estonia ( EVS )
• Hong Kong, China (
ITCHKSAR )
• Hungary ( MSZT )
• India ( BIS )
• Luxembourg ( ILNAS )
• Malta ( MSA )
• Mongolia ( MASM )
• Russian Federation (
GOST R )
• Saudi Arabia ( SASO )
• Switzerland ( SNV )
• Thailand ( TISI )
• Uruguay ( UNIT )
• Zimbabwe ( SAZ )
18. The meeting was attended the by
international community of laboratorians
• Laboratorians
• Accreditation bodies
• Medical Device Manufacturers
• Metrologists
• Calibration authorities
• Medical Laboratory Consultants
• Organizational Representatives
– CAP, WHO, WASP, OECD,EDMA, IBWM,ELM,IFCC, ILAC
19. ISO Technical Committee 212
• Working Groups
• 1 - Quality and competence in the medical laboratory
• 2 - Reference systems
• 3 - In vitro diagnostic products
• 4 - Antimicrobial susceptibility testing
20. Canadian Participation in
ISO Technical Committee 212
• Canadian Advisory Committee to ISO TC 212
• Required by Standards Council of Canada
• Hosted by Canadian Standards Association
• Participates in all four working groups
• Representatives from all laboratory disciplines.
• Regional representation
• Also responsible for CSA standards for medical
laboratories (fume hoods, safety cabinets, sharps containers).
21. 21
Standards Developed by ISO TC 212
• Seventeen standards in the areas of
– Laboratory Quality Management
– Safety
– Risk
– Point of Care
– Calibrators
– Validation
– Susceptibility Testing
– Traceability
– Label Symbols
• Canadian lead writing teams
24. 24
Not all laboratories are the same
Medical A laboratory of many integrated procedures
intended for diagnosis, confirmation,
documentation of human health information
Community
Hospital
Public Health
Testing A laboratory of limited stand-alone procedures
intended to confirm conformity of a product to its
expected target or goal
Manufacturing
Electrical
Water
Food
Mining
Public Health
Calibration A laboratory of a very limited range of
procedures intended to ensure traceability of
equipment or material to highest level possible.
Reference
NIST
25. 25
ISO 15189:2007
Medical Laboratories – particular requirements for
quality and competence.
• First published in 2003
• Adopted as a Canadian National Standard
• Adopted as the basis for provincial accreditation in
Ontario, Quebec, Atlantic Canada
• Recognized as the source for quality management in
requirements Alberta, Saskatchewan, Manitoba.
• Recognized as a source of quality management
requirements in British Columbia
• Quality and competence are holistic issues.
• 15189 is not laboratory discipline specific.
26. 26
ISO 15189 requirements
Management Requirements
1. Organization
2. Quality Management System
3. Document Control
4. Review of Contracts
5. Referral Laboratories
6. External Services and Supplies
7. Identification and control of
non-conformities
8. Corrective Actions
9. Preventive Actions
10. Continual Improvement
11. Quality and Technical Records
12. Internal Audits
13. Management Review
Technical Requirements
1. Personnel
2. Accommodation / environment
3. Laboratory Equipment
4. Pre-examination procedures
5. Examination procedures
6. Assuring quality of examinations
7. Post-examination procedures
8. Reporting Results
27. 27
15189 Examples
• Organization
– A medical laboratory shall be a legal entity.
– Medical laboratories shall be designed to meet patient needs.
– Laboratory personnel responsibilities shall be defined.
– Laboratory management shall provide personnel with the
resources and authority to perform their duties.
– Laboratory policies and procedures shall protect confidential
information.
– The laboratory shall appoint a quality manager.
– The laboratory shall have technical management for overall
responsibility of technical operations and the provision of
resources needed to ensure the required quality of laboratory
procedures.
28. 28
15189 and the Laboratory Director
• The laboratory shall be directed by a person or persons having
executive responsibility and the competence to assume
responsibility for the services provided. (note: competence is the
product of basic, academic, postgraduate, continuing education, and
training and experience of several years in a medical laboratory).
• The laboratory director shall be responsible for professional,
scientific, consultative or advisory organization, administrative
and educational matters.
• The laboratory director need not perform all
responsibilities personally. However it is the laboratory
director who remains responsible for the overall
operation and administration of the laboratory, for
ensuring quality services provided for patients.
29. 29
15189 and Management Review
• Laboratory management shall review the laboratory’s quality
management system and all of its medical services, including
examination and advisory activities to ensure their continuing
suitability and effectiveness in support of patient care and to
introduce any necessary changes or improvements.
• The results of the review shall be incorporated into a plan that
includes goals, objectives and action plans.
• The typical period for conducting a management review is once
every twelve months.
• Management review shall take into account, follow-up of previous
review, status of corrective actions, reports from managers and
supervisors, internal audits, assessments of external bodies, quality
indicators, outcome of EQA, feedback (complaints), non-
conformities, continual improvement processes, evaluation of
suppliers.
30. 30
15189 and Personnel
• Laboratory management shall have an organization plan, personnel
policies and job descriptions that define qualifications and duties
for all personnel.
• Laboratory management shall authorize personnel to perform
particular tasks.
• Personnel shall have training specific to quality assurance and
quality management for services offered.
• There shall be a continuing education program available to staff at
all levels.
• Employees shall be trained to prevent or contain the effects of
adverse incidents.
• The competency of each person to perform assigned tasks shall be
assessed following training and periodically thereafter. Retraining
and reassessment shall occur when necessary.
31. 31
15189 and the Quality Manager
• The laboratory shall appoint a quality manager with
delegated responsibility and authority to oversee
compliance with the requirements of the quality
management system.
• The quality manager shall report directly to the level of
laboratory management at which decisions are made
on laboratory policy and resources.
• The quality manager shall plan, organize and conduct
internal audits.
32. 32
15189 and assuring the quality of
examination procedures
• The laboratory shall design internal quality control.
• It is important that the control system provide staff with clear and
easily understood information.
• The laboratory shall determine the uncertainty of results where
relevant and possible.
• A programme for calibration of measuring systems and verification
of trueness shall be designed and performed so as to ensure that
results are traceable to SI units
• The laboratory shall participate in a suitable inter-laboratory
comparison.
• The laboratory shall use suitable reference materials, certified to
indicate the characterization of the material.
• For those examinations performed using different procedures or
equipment at different sites, there shall be a defined mechanism for
verifying the comparability of results throughout the clinically
appropriate intervals.
33. 33
15189 and the Internal Audit
• Internal audits shall address all elements of the
system, both management and technical, and
emphasize areas critically important to patient care.
• Audits shall be planned, organized and carried out by
the quality manager
• Procedures of the audits shall be documented and
carried out within an agreed upon time.
• The main elements of the quality system should be
subject to internal audit once every 12 months.
• The results of internal audits shall be submitted to
laboratory management for review.
34. 15189 Continuous Improvement
• Laboratory management shall have a policy and procedure to be
implemented when it detects that any aspect of its examinations
does not conform with its own procedures or the agreed upon
requirements of the quality management system, or the
requesting physician.
• Procedures for corrective action shall include an investigative
process to determine the underlying cause or causes of the
problem.
• Corrective action shall be appropriate to the magnitude of the
problem and commensurate with the risk.
• These shall lead, where appropriate to preventive actions.
34
35. and…
• All operational procedures shall be systematically reviewed by
laboratory management at regular intervals in order to identify
potential sources of non-conformance.
• Action plans for improvement shall be developed, documented and
implemented.
• After the action has been implemented, management shall evaluate
the effectiveness of the action.
• Management shall implement quality indicators for systematically
monitoring and evaluating the laboratory’s contribution to patient
care.
• When opportunities for improvement are detected, management
shall address them regardless of where they occur.
37. So, what can you say about quality
management and ISO15189?
• Very broad document.
• Consistent with the history and tradition of
quality management (PDCA, 14 Essentials, 4
Absolutes).
• Gaining much international use and respect.
• In one form or another, all laboratory physicians
will be dealing directly and indirectly with the
requirements cited in this document.
44. 44
In conclusion:
• Medical laboratories have a requirement and an
expectation for quality.
• Medical laboratories have a network of quality
partners with whom to interact.
• Medical laboratories have a history of quality
management from other sectors from whom they
can learn.
• Medical laboratories have an international
standard upon which they can base their quality
management.
45. 45
Every Laboratorian has a
responsibility and an obligation to
be informed about quality and its
management.